Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Perspective Therapeutics And 3 Other Stocks Under $1 Insiders Are Buying

Author: Avi Kapoor | December 19, 2023 09:29am

The Dow Jones index closed slightly higher on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Tharimmune

  • The Trade: Tharimmune, Inc. (NASDAQ:THAR) CEO Randy Milby acquired a total of 29,000 shares an average price of $0.50. To acquire these shares, it cost around $14,587.
  • What’s Happening: Tharimmune recently announced topline data with TH104, its lead candidate for moderate-to-severe pruritus in chronic liver disease patients.
  • What Tharimmune Does: Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases.

Perspective Therapeutics

  • The Trade: Perspective Therapeutics, Inc. (NASDAQ:CATX) Director Lori A Woods acquired a total of 185,200 shares at an average price of $0.27. To acquire these shares, it cost around $49,989.
  • What’s Happening: Perspective Therapeutics recently announced it agreed to fully divest its brachytherapy business.
  • What Perspective Therapeutics Does: Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body.

Check This Out: Aware And 3 Other Stocks Under $2 Insiders Are Buying

SHF Holdings

  • The Trade: SHF Holdings, Inc. (NASDAQ:SHFS) CEO Sundie Seefried acquired a total of 24,700 shares at an average price of $0.96. The insider spent around $23,737 to buy those shares. The company’s Director also bought 15,000 shares of the company.
  • What’s Happening: On Nov. 14, SHF Hldgs posted a loss for the third quarter.
  • What SHF Holdings Does: SHF Holdings Inc is a financial services provider to cannabis-related businesses.

Dalrada Financial

  • The Trade: Dalrada Financial Corporation (OTC:DFCO) CEO Brian Bonar acquired a total of 9,000 shares at an average price of $0.29. The insider spent around $2,616 to buy those shares.
  • What’s Happening: The company’s stock jumped 26% over the past six months.
  • What Dalrada Financial Does: Dalrada Financial Corp is a United States-based company engaged in providing financial, insurance, benefit, and business process outsourcing products and services to companies.

Don’t forget to check out our premarket coverage here

Posted In: CATX DFCO SHFS THAR

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist